EGRX Overview
Upcoming Projects (EGRX)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (EGRX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (EGRX)
-
Eagle Pharma's (EGRX) NDA for Liquid Version of Lilly's (LLY) Alimta Granted PDUFA Date of October 30th
Tickers: EGRX, LLY
Occurred on: Oct 27, 2017 -
PDUFA target date set to July 23, 2017 for Eagle Pharma's(EGRX) Ryanodex in treating Exertional Heat Stroke (EHS)
Ticker: EGRX
Occurred on: Jul 26, 2017 -
Eagle Pharma (EGRX) Submits Rolling New Drug Application (NDA) to FDA Seeking Approval of Ryanodex in Exertional Heat Stroke
Ticker: EGRX
Occurred on: Nov 11, 2016 -
Eagle Pharmaceuticals Receives Complete Response Letter from FDA on KANGIO (RTU bivalirudin) Application
Ticker: EGRX
Occurred on: Mar 18, 2016 -
Eagle Pharmaceutical's Non-Alcohol Docetaxel Injection Now Commercially Availaible
Ticker: EGRX
Occurred on: Feb 03, 2016 -
FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation Approved in U.S.
Ticker: EGRX
Occurred on: Dec 24, 2015
Strategic Initiatives (EGRX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
